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Özet
Amaç: Bu çalışmanın amacı, epilepsi cerrahisinden sonra nöbet kontrolü, antiepileptik ilaç kullanımı, yaşam kalitesindeki değişim ve bunlara 
paralel olarak epilepsiye bağlı sağlık harcamalarında ve ilaç maliyetindeki değişimi belirlemektir.
Gereç ve Yöntem: İlaca dirençli epilepsi nedeniyle takip edilen 24 hasta (11 kadın, 13 erkek) çalışmaya alındı. Cerrahi öncesi ve sonrası nö-
bet sıklığı, antiepileptik sayıları belirlenerek SF-36 ölçeği uygulandı. Cerrahi öncesinde ve sonrasında epilepsiye bağlı sağlık harcamaları ve 
antiepileptik ilaç giderleri hastane bilgi yönetim sisteminden ve ulusal sosyal güvenlik kurumu veri tabanından elde edildi.
Bulgular: Yirmi dört hastaya ilaca dirençli epilepsisi nedeniyle ATLE ya da lezyonektomi uygulandı. Ortalama 24 ay sonunda hastaların 
%67’sinde nöbet kontrolü (ILAE sınıf I ve II) sağlandı. Postoperatif antiepileptik ilaç sayısında belirgin azalma görüldü (p=0.005). SF-36’ya göre 
hastaların genel sağlık durumlarını algılayışlarında, duygusal sorunlara bağlı kısıtlılıklarında düzelme tespit edildi (p<0.005). Maliyet analizin-
de cerrahi uygulanan hastalarda hem antiepileptik ilaç maliyeti hem de epileptik nöbetlere bağlı sağlık giderlerinde belirgin azalma olduğu 
saptandı (p<0.005). 
Sonuç: İlaca dirençli epilepside cerrahinin nöbet kontrolündeki etkinliği ve yaşam kalitesi üzerine yararları ve bunlara paralel ekonomik yarar-
ları dikkat çekicidir. Hem medikal hem de ekonomik açılardan olumlu sonuçları olan cerrahi uygulamaların ülkemizde artabilmesi için ilaca di-
rençli epilepsisi olan hastaların bu konuda özelleşmiş ve cerrahi uygulayan merkezlere daha fazla yönlendirilmeleri gerekmektedir.
Anahtar sözcükler: Maliyet; epilepsi; yaşam kalitesi; cerrahi. 
Summary
Objectives: The aim of this study was to evaluate postoperative changes in terms of seizure frequency, antiepileptic drug (AED) consumption 
and quality of life, and in parallel with this, to determine the changes in AED and healthcare costs after surgery.
Methods: Twenty-four patients who underwent epilepsy surgery with medically intractable epilepsy were included in the study. Demo-
graphic features, seizure frequency and number of AEDs were obtained, and the Short Form Health Survey (SF-36) was administered pre- and 
postoperatively. Financial records were accessed via the university hospital database and the central network database of the national social 
security administration.
Results: ATLE or lesionectomy was carried out in 24 patients. During the mean follow-up period of 24 months, 67% of patients achieved Class 
1 and 2 seizure control and a significant reduction in the number of AEDs (p<0.005). On the SF-36, the general perception of health and role 
limitations due to emotional problems significantly improved postoperatively. The cost analysis revealed a significant reduction in AED and 
healthcare costs due to epilepsy in patients who underwent surgery (p<0.005). 
Conclusion: Surgical interventions for medically intractable epilepsy are effective in seizure control and have a notable beneficial effect on 
quality of life as well as healthcare costs. These medical and economic benefits of epilepsy surgery should encourage Turkish neurologists to 
refer patients to comprehensive epilepsy centers.
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Introduction
Antiepileptic drugs (AED) are not adequate to control 
seizures effectively in approximately 30 to 40% of individu-
als with epilepsy.[1,2] The unpredictable and recurrent sei-
zures lead to cognitive, emotional and behavioral problems 
as well as deterioration in quality of life related to decline 
in social functioning, employment, marital status and self-
confidence.[3-6] Furthermore, patients with epilepsy are on 
multiple antiepileptic drugs and suffer from stigmata, limi-
tations in driving and independent living.[7,8] The impact of 
epilepsy is not limited to only physical limitations but also 
epilepsy patients have high rates of anxiety and depres-
sion, and experience restrictions in social life. Therefore, 
extensive impact of the disease affects the patients’ quality 
of life. An increased interest and research into assessment 
of health related quality of life in epilepsy revealed higher 
quality of life in surgery patients with respect to nonsurgi-
cal controls with intractable epilepsy.[9] Furthermore, most 
epilepsy surgery patients report a positive overall impact 
of the procedure on their lives and a high willingness to 
undergo surgery again if that choice had to be made. The 
significant amelioration of health related quality of life has 
been reported in short term studies, in studies concerning 
long term outcome beyond five years and in studies with 
10 years and more of follow-up.[10-12]
Surgical procedures are effective alternatives of antiepi-
leptic drugs in patients with medically refractory epilepsy. 
Its use is increased, although it is frequently considered 
an underused treatment option especially in developing 
countries.[13,14] There is a serious gap between the number 
of patients who could benefit from epilepsy surgery and 
those who actually receive this treatment in Turkey. The 
reasons for few implementation of epilepsy surgery may 
be the poor awareness of epilepsy surgery among health-
care professionals and the lack of health-care infrastruc-
ture to identify patients with medically refractory epilepsy. 
Recently, Turkish Chapter of International League against 
Epilepsy is working on to start an action in order to in-
crease awareness of epilepsy surgery among health-care 
professionals and general population. In parallel to this is-
sue, we aimed to report the results of our series in order 
to draw attention to positive results of epilepsy surgery 
and its cost-effectiveness. Although, it can be argued that 
cost analysis and quality of life issues in epilepsy surgery 
should be discussed separately, the main issue we want 
to emphasize besides reporting the results of our series, 
is to draw attention to the benefits of surgical treatment 
of the epilepsy in well selected patients. It is fairly impor-
tant because it is estimated there are many more patients 
than who can receive optimal therapy for epilepsy and can 
be candidates for epilepsy surgery. In particular our aim is 
to increase awareness of the surgical option for patients 
with intractable epilepsy among Turkish neurologists and 
promote to refer them to comprehensive epilepsy centers. 
Materials and Methods
The patients who underwent epilepsy surgery in Pamuk-
kale University Medical Faculty between 2006 and 2010 
with intractable epilepsy were enrolled in the study. The 
demographic data related to epilepsy were obtained from 
structured forms recorded during specified epilepsy clini-
cal visits. 
a) Surgery: Patients who experience epileptic seizure de-
spite at least two antiepileptic drugs and leading to severe 
disability are defined as medically refractory. Presurgical 
workup included long term video EEG monitorization, cra-
nial magnetic resonance imaging (MRI), and neuropsycho-
logical testing. Ictal SPECT, FDG-PET studies are performed 
when necessary. In non-lesional patients subdural elec-
trodes were implanted according to a hypothesis based on 
the data obtained by presurgical evaluations. Electrocorti-
cal stimulation was applied in order to define seizure focus 
and eloquent cortex in selected patients. In patients with 
defined seizure focus, anterior temporal lobectomy or ex-
tratemporal cortical resections were carried out. 
b) Seizure outcome: Seizure outcome is evaluated accord-
ing to the classification of ILAE for seizure outcome fol-
lowing epilepsy surgery.[15] According to this classification, 
class 1 is completely seizure free and no auras; class 2 is 
only auras and no other seizures; class 3 is 1-3 seizure days 
per year with or without auras; class 4 is 4 seizure days per 
year to 50% reduction of baseline seizure days with or with-
out auras; class 5 is less than 50% reduction of baseline sei-
zure days with or without auras; class 6 is more than 100% 
increase of baseline seizure days with or without auras.[15]
c) Antiepileptic drug usage: The number of AEDs and 
their dosages are obtained before and 18 months after 
the surgery. A comparison analysis is carried out for the 
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number of AEDs and the percentage of dose reduction is 
calculated.
d) Quality of life assessment: In order to evaluate quality 
of life, Short Form of the Quality of Life Scale (SF-36) was 
applied before and at 6th, 12th and 18th month after epi-
lepsy surgery. SF-36 is a survey that includes 36 items and 
assesses the quality of life at 8 dimensions. The validity and 
reliability of Turkish translation were proved previously.
[16] The 8 dimensions that are physical and social function-
ing, role limitations due to physical health and emotional 
problems, emotional wellbeing, energy/fatigue, pain and 
general health perception are evaluated. The total score is 
between 0-100 points. 0 shows bad health condition and 
100 shows good health condition.
e) Cost analysis: The direct medical expenses related to 
epilepsy included the cost of physician visits, emergency 
room visits, hospitalizations due to seizures, diagnostic 
laboratory testing (such as blood tests and EEG etc.) and 
neuroimaging (MRI, computerized tomography). Health-
care costs for the 2 years prior to surgical evaluation and 
for 2 years afterward were calculated from records of the 
central network database of the national social security ad-
ministration and university hospital database. Antiepilep-
tic drug costs are calculated separately from direct medi-
cal expenses. The preoperative (the last prescribed before 
undergoing surgery) and the postoperative (the most cur-
rent) regimens were obtained from the electronic medi-
cal records. The monthly cost of each drug was calculated 
using the price list indicated by Turkish Ministry of Health 
(2009 edition). The total cost of preoperative and postop-
erative drugs were calculated and compared. 
Surgery expenses included presurgical work-up (long term 
video-EEG monitorization, invasive EEG monitorization, 
intracranial electrodes, cranial MRI, PET, SPECT, neuropsy-
chological tests), and hospitalization for epilepsy surgery. 
All of the surgical expenses are accessed via electronic 
database of the purchasing department of the hospital. 
Surgery cost / preop direct medical expenses year - postop 
direct medical expenses per year gave the time required 
for the surgery turn out. 
f) Statistical analysis: Related samples t-test is used to 
analyze the data before and after surgery (SPSS (version 
17.0) for Windows) and p value below 0.05 is accepted as 
statistically significant.
Results
A total of 24 (11 female, 13 male) patients who were oper-
ated between 2006 and 2010 due to medically refractory 
epilepsy are enrolled in the study. Demographic and epi-
lepsy related data are summarized in Table 1. The presur-
gical work-up revealed temporal lobe epilepsy and ante-
rior temporal lobectomy with amygdalohippocampectomy 
(ATLE) is applied in 21/24 patients. In three patients seizures 
were related to extratemporal lesions and corticectomy 
was applied to the related regions (Table 2). The pathologi-
cal examination of the resected material revealed mesial 
temporal sclerosis in 80% of the ATLE patients (Table 2).  In 
3/24 patients reversible complications occurred during the 
early postoperative period such as wound infection in 2/24 
and subdural hematoma and hydrocephalus in 1/24. 
a) Seizure outcome: Approximately 2 years of follow-up 
revealed that about 67% of ATLE patients achieved to com-
plete seizure freedom (12/21) or experiencing only auras 
(2/21). 33% of the ATLE patients experienced rare seizures 
(3/21) or up to 50% reduction in seizure days from the 
baseline (4/21) (Table 2). 
b) Antiepileptic drugs: The number of antiepileptic drugs 
was significantly reduced in the postoperative period 
(p=0.005) and a dose reduction of 44% was achieved in the 
current antiepileptic drug regime of patients undergoing 
ATLE and corticectomy. 
c) Quality of life: The SF-36 assessments before and after (at 
6th, 12th and 18th months) ATLE or corticectomy revealed 
a permanent improvement in not only patients’ perception 
of their health in general, but also emotional wellbeing, en-
ergy and role limitations due to emotional problems (Table 
3). At the 18th month control the patients reported that they 
contributed social life better. Furthermore, there was a nega-
tive correlation between the role limitations due to physical 
health and number of antiepileptic drugs (r= -0.372, p<0.05). 
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Table 1. Summary of demographic data
Mean age at surgery (yr) 31.83±12.51
Mean duration of disease (yr) 16.57±7.12
Mean follow-up period (mo) 25.00±15.33
d) Medical and surgery costs: The mean of direct medi-
cal costs for ATLE/corticectomy patients (n=24) was 3265 
TL (€1632) per year preoperatively and 691 TL (€345) per 
year postoperatively (p<0.05). Antiepileptic drug cost 
was 327 TL (€166) per month preoperatively versus 193 
TL (€96) postoperatively (p<0.05). The surgery costs in pa-
tients with ATLE/ corticectomy with or without invasive 
monitorization (n=24) was 12255 TL (€6125) and the sur-
gery cost turn out is approximately 4 years (Table 4). 
Discussion
In Turkey, the active epilepsy prevalence is around 1% 
which is similar to many developing countries.[17-24] Ac-
cording to this, considering that approximately 700,000 
epilepsy patients exist in Turkey, about 10% of this epilepsy 
population is surgery candidates. The benefits of epilepsy 
surgery in terms of seizure outcome and improvements in 
life quality are beyond controversy in well selected patient 
groups, especially in temporal lobe epilepsy with hippo-
campal sclerosis. Despite the enormous amount of pa-
tients who can benefit from epilepsy surgery, the number 
of epilepsy surgery operations per year is approximately 
100 cases. The main reason of poor implementation of 
epilepsy surgery seems to be the inadequate number of 
comprehensive epilepsy centers as well as poor referral 
of patients to existing epilepsy centers where standard 
epilepsy surgery is implemented. Epilepsy surgery com-
mission of Turkish chapter of ILAE has started to work on 
action intending to increase awareness about epilepsy as 
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Table 2. Surgery type, invasive monitoring, pre- and postoperative AED numbers, percentage of dose reductions in 
current drugs, MRI findings, histopathology and ILAE outcome scales 
No Surgery Invasive Preop Postop % of dose MRI scale Histopathology ILAE outcome
 type monitoring AED # AED # reduction in 
     current drug/s 
1 ATLE No 2 2 0 TGT DA 1
2 ATLE Yes 2 2 0 PNH, ipsi HA MTS 2
3 ATLE No 2 1 25  MTS MTS 1
4 ATLE No 2 1 75  MTS MTS 1
5 ATLE No 1 1 75 CA CA 1
6 ATLE No 3 2 75  HA MTS 1
7 ATLE No 1 1 75  MTS MTS 1
8 ATLE Yes  2 2 25  HA MTS 1
9 ATLE Yes 5 1 50 MTS MTS 1
10 ATLE Yes 3 1 25  HA MTS 4
11 ATLE Yes 3 2 60 HA MTS 1
12 ATLE Yes 3 2 50 HA CIRG 1
13 ATLE No 2 1 70 MTS Calcification, IR 1
14 ATLE No 3 3 25 MTS MTS 3
15 ATLE No 1 0 100 MTS MTS 2
16 ATLE Yes 6 3 40  MTS MTS 4
17 ATLE No 3 2 75 MTS MTS 3
18 ATLE Yes 2 2 43 MTS MTS 3
19 ATLE No 3 3 0 HE+MTS MTS 4
20 ATLE Yes 2 2 25 MTS MTS 4
21 ATLE No 3 2 35 MTS MTS 1
22 CC Yes 3 3 0 CDCG CD 4
23 FC Yes 4 2 30 Normal CD 4
24 PC Yes  2 0 100 PGT Astrocytoma 1
ATLE: Anterior temporal lobectomy and amygdalohippocampectomy; PNH: Periventricular nodular heterotopy; HA: Hippocampal atrophy; 
MTS: Mesial temporal sclerosis; CC: Cingulate corticectomy; FC: Frontal corticectomy; PC: Parietal corticectomy; HE: Hypoxic encephalomalasia; 
CDCG: Cortical dysplasia at cingulate gyrus; TGT: Temporal glial tumor; PGT: Parietal glial tumour; CA: Cavernous angioma; DA: Diffuse astrocytoma; 
CD: Cortical dysplasia; CIRG: Chronic inflammation reactive gliosis; IR: Ischemic necrosis.
a surgically remediable disease among health-care profes-
sionals and general population. In parallel to this action we 
believe that it is important to report satisfactory results in 
terms of seizure outcome and quality of life. 
The quality of life in epilepsy population is declined in 
many aspects and the most significant factors affecting the 
quality of life and daily living activities are seizure frequen-
cy and number of antiepileptic drugs used.[13,25] Epilepsy 
surgery can effectively reduce seizure frequency with very 
low morbidity. Furthermore, within a year following sur-
gery reduction of antiepileptic drug dosage is possible in 
completely seizure free patients, thus reducing the side ef-
fects. In addition to all these benefits patients can accom-
modate to social life effectively by gaining independence 
and feeling less limited in working life, marital relations 
and driving. Independent from quality of life multiple drug 
usage, routine clinic controls, and hospitalizations due to 
complications of epileptic seizures, emergency room ad-
mittances due to epileptic seizures, status epilepticus or 
secondary traumas constitute an important amount of di-
rect medical expenses related to epilepsy. 
The quality of life among epilepsy patients is lower than 
that of developed countries which may be related to 
cultural, social and economic differences as well as non-
supportive health care system.[25,26] In Turkey there are few 
studies evaluating quality of life after epilepsy surgery. Ay-
demir et al.[25] used SF-36 to evaluate quality of life in pa-
tients with hippocampal sclerosis (HS) who had selective 
amygdalohippocampectomy (SAH). Their study revealed 
that operated patients’ quality of life scores were higher in 
all dimensions of SF-36 when compared to patients with 
HS but not operated on. However, only the improvement 
in role limitations due to emotional problems reached to 
statistical significance. The main factors affecting the qual-
ity of life were high seizure frequency and concomitant 
diseases. Furthermore, antiepileptic drug usage was nega-
tively correlated to the quality of life. In about 48% of the 
patients regained their independence and improved in so-
cial activities after the surgery.[25] In another study psychi-
atric status, degree of disability and quality of life (WHO-
QOL-BREF) were assessed.[27] The quality of life assessments 
did not show significant difference postoperatively, how-
ever the patients contributed social life better and were 
satisfied from their health in general.[27]
In our study a significant improvement was evident in 
seizure control (66% seizure freedom in the second year) 
in patients with ATLE and lesionectomy. Our results are 
congruous with the previous studies reporting a 48-84% 
seizure freedom among the patients with temporal lobe 
epilepsy treated with ATLE.[28-33] Unlike previous studies 
evaluating quality of life after epilepsy surgery that men-
tioned above, this group of patients achieved a significant 
reduction in current antiepileptic drug dosage and im-
proved in many dimensions of SF-36. The improvement in 
quality of life determined at 6th month persisted also at 
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Table 3. The significant difference is demonstrated in SF-36 subgroup scales in the postoperative period 
when compared to preoperative period
SF-36 Subgroup scales 6th month 12th month 18th month
 p p p
Physical functioning n.s. n.s. n.s.
Role limitations due to physical health 0.05 0.05 0.05
Role limitations due to emotional problems 0.001 0.005 0.005
Energy/ fatigue 0.003 0.01 0.05
Emotional wellbeing 0.005 0.001 0.001
Social functioning n.s. n.s. 0.05
Pain n.s. n.s. n.s.
General health perception 0.000 0.000 0.000
Table 4. Pre- and postoperative cost analysis
 Medical costs (per yr) AED costs (per mo)
Preoperative 3265 TL 3927 TL
Postoperative 691 TL 2322 TL
p <0.05 <0.05
12th and 18th month controls. Furthermore, patients felt 
more confident and contributed to social life better 18 
months after the surgery. In a randomized controlled study 
assessing the quality of life after epilepsy surgery due to 
temporal lobe epilepsy revealed that quality of life started 
to improve at the earliest 3rd month following surgery and 
persisted until 12th month.[33] Another large prospective 
surgery series (n=396) reported immediate improvement, 
that maintained for 5 years, in quality of life after surgery.[34] 
The cost analysis of epilepsy surgery is evaluated by differ-
ent researchers from different countries. There is an agree-
ment that surgical treatment of temporal lobe epilepsy is 
a cost-effective treatment in a middle-term even without 
indirect medical costs.[35] Moreover, surgical treatment of 
temporal lobe epilepsy is cheaper than medical therapy. [36] 
Recently it has been reported that epilepsy surgery is as-
sociated with significant postoperative savings in antiepi-
leptic drug cost.[37] Another study revealed that seizure free 
patients use substantially less health-care after surgery 
than before surgery.[38] Besides, in patients with TLE whose 
seizures persisted the health-care costs remained stable 
over 2 years postsurgery.[38] In parallel to these results our 
study also revealed that direct medical expenses reduced 
about 78%, after ATLE surgery and the surgery costs seem 
to turn out in 4 years. 
There are some limitations of this study. It may be argued 
that the number of patients is not enough to say epilep-
sy surgery reduces direct healthcare expenses, but these 
preliminary results are enough to predict patients benefit 
from epilepsy surgery in general terms. Some patients who 
are seizure free for 2-3 years after the surgery may experi-
ence seizure recurrence in the long term; therefore longer 
follow-up is required to make absolute conclusions. De-
spite the limitations of this study, it showed that to do epi-
lepsy surgery is worth while in well selected TLE patients 
who are the best candidates to benefit both in terms of sei-
zure control and quality of life. The benefits are not limited 
to seizure control and achieving a better quality of life but 
also economic gains are notable. 
In conclusion, it is important to realize that epilepsy is a 
surgically remediable disease and postoperative benefits 
are undeniable. Therefore, it is important to emphasize to 
identify patients with medically refractory epilepsy and 
prompt their referral to comprehensive epilepsy centers.
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